Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis

Journal of Neuroimmunology

Volumn 245, Issue 1-2, 2012, Pages 98-101

  Lopez de Lapuente, A ^a   Alloza, I ^a   Goertsches, R ^b   Zettl, U K ^b   Urcelay, E ^c   Arroyo, R ^c   Comabella, M ^d   Montalban, X ^d   Antiguedad A ^e   Vandenbroeck, K ^a,f  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL DE BASURTO   (Spain)

^f BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

Interferon ; Interleukin 28 receptor alpha; Multiple sclerosis; Polymorphism

Indexed keywords

ADULT; ARTICLE; BASQUE SPANISH; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; IL28RA GENE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; RECEPTORS, CYTOKINE; RISK FACTORS; YOUNG ADULT;

EID: 84859641473     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.02.005     Document Type: Article

References (24)

1. Ban M., Goris A., Lorentzen A.R., Baker A., Mihalova T., Ingram G., Booth D.R., Heard R.N., Stewart G.J., Bogaert E., Dubois B., Harbo H.F., Celius E.G., Spurkland A., Strange R., Hawkins C., Robertson N.P., Dudbridge F., Wason J., De Jager P.L., Hafler D., Rioux J.D., Ivinson A.J., McCauley J.L., Pericak-Vance M., Oksenberg J.R., Hauser S.L., Sexton D., Haines J., Sawcer S., Wellcome Trust Case-control Consortium (WTCCC), Compston A. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur. J. Hum. Genet. 2009, 17:1309-1313.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and Haplotype maps. Bioinformatics 2005, 21:263-265.
3. Chae S.C., Park Y.R., Li C.S., Lee J.H., Yang Y.S., Zhang Q., Kim K.S., Chung H.T. Analysis of the variations in IL-28RA gene and their association with allergic rhinitis. Exp. Mol. Med. 2006, 38:302-309.
4. Clarke G.M., Cardon L.R. Aspects of observing and claiming allele flips in association studies. Genet. Epidemiol. 2010, 34:266-274.
5. Dumoutier L., Tounsi A., Michiels T., Sommereyns C., Kotenko S.V., Renauld J.C. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J. Biol. Chem. 2004, 279:32269-32274.
6. Fogdell A., Hillert J., Sachs C., Olerup O. The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 1995, 46:333-336.
7. Fortunato G., Calcagno G., Bresciamorra V., Salvatore E., Filla A., Capone S., Liguori R., Borelli S., Gentile I., Borrelli F., Borgia G., Sacchetti L. Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes. J. Interferon Cytokine Res. 2008, 28:141-152.
8. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
9. Gong Q.M., Kong X.F., Yang Z.T., Xu J., Wang L., Li X.H., Jin G.D., Gao J., Zhang D.H., Jiang J.H., Lu Z.M., Zhang X.X. Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection. J. Viral Hepat. 2009, 16:674-680.
10. Jersild C., Svejgaard A., Fog T. HLA antigens and multiple sclerosis. Lancet 1972, 1:1240-1241.
11. Johnson A.D., Handsaker R.E., Pulit S.L., Nizzari M.M., O'Donnell C.J., de Bakker P.I. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24:2938-2939.
12. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., Donnelly R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003, 4:69-77.
13. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. Am. J. Hum. Genet. 2007, 80:531-538.
14. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50:121-127.
15. Oksenberg J.R., Baranzini S.E. Multiple sclerosis genetics-is the glass half full, or half empty?. Nat. Rev. Neurol. 2010, 6:429-437.
16. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
17. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., Maller J., Sklar P., de Bakker P.I.W., Daly M.J., Sham P.C. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 2007, 81:559-575.
18. Rodríguez-Ezpeleta N., et al. High-density SNP genotyping detects homogeneity of Spanish and French Basques, and confirms their genomic distinctiveness from other European populations. Hum. Genet. 2010, 128:113-117.
19. Sawcer S., Hellenthal G., Pirinen M., Spencer C.C., Patsopoulos N.A., Moutsianas L., Dilthey A., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
20. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Clegg C., Foster D., Klucher K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003, 4:63-68.
21. Skol A.D., Scott L.J., Abecasis G.R., Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 2006, 38:209-213.
22. Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 2010, 42:985-990.
23. Vandenbroeck, K. in press. Cytokine gene polymorphisms and human autoimmune disease in the era of genome-wide association studies. J. Interferon Cytokine Res. doi:. http://doi:10.1089/jir.2011.0103.
24. Vandenbroeck K., Alvarez J., Swaminathan B., Alloza I., Matesanz F., Urcelay E., Comabella M., Alcina A., Fedetz M., Ortiz M.A., Izquierdo G., Fernandez O., Rodriguez-Ezpeleta N., Matute C., Caillier S., Arroyo R., Montalban X., Oksenberg J.R., Antigüedad A., Aransay A. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis. Genes Immun. 2012, 13:21-28.